High-grade focal areas in low-grade central osteosarcoma: high-grade or still low-grade osteosarcoma? View Full Text


Ontology type: schema:ScholarlyArticle      Open Access: True


Article Info

DATE

2015-10-29

AUTHORS

Alberto Righi, Anna Paioli, Angelo Paolo Dei Tos, Marco Gambarotti, Emanuela Palmerini, Manuela Cesari, Emanuela Marchesi, Davide Maria Donati, Piero Picci, Stefano Ferrari

ABSTRACT

BackgroundHigh-grade foci (grade 3 according to Broder’s grading system) are sometimes detected in low-grade (grade 1 and 2) central osteosarcoma. The aim of this study was to retrospectively evaluate the clinical outcome in patients upgraded to high grade (grade 3) after a first diagnosis of low-grade osteosarcoma, following the detection of high-grade areas (grade 3) in the resected specimen.MethodsOf the 132 patients with a diagnosis of low-grade central osteosarcoma at surgical biopsy at our Institute, 33 patients were considered eligible for the study.ResultsMedian age was 37 (range 13–58 years). Location was in an extremity in 29 patients (88 %). Post-operative chemotherapy was given in 22 (67 %) patients. Follow-up data were available for all patients, with a median observation time of 115 months (range 4–322 months). After histological revision, areas of high-grade (grade 3) osteosarcoma accounting for less than 50 % of the tumor were found in 20 (61 %) patients, whereas the majority of the tumor was composed of a high-grade (grade 3) component in 13 (39 %) patients. In the 20 cases of low-grade osteosarcoma with high-grade foci (grade 3) in less than 50 % of the tumor, 9 patients did not receive adjuvant chemotherapy; only one of them died, of unrelated causes. In the adjuvant chemotherapy group (11 out of 20 patients), one patient developed multiple lung metastases and died of disease 39 months after the first diagnosis. In the other 13 cases of low-grade osteosarcoma with high-grade foci (grade 3) in more than 50 % of the tumor, 12 patients received adjuvant chemotherapy: 2 had recurrence, 4 developed multiple lung metastases and 3 died of disease. The only patient who did not receive chemotherapy is alive without disease 232 months after complete surgical remission.ConclusionOur data indicate that patients with a diagnosis of low-grade osteosarcoma where the high-grade (grade 3) component is lower than 50 % of the resected specimen, may not require chemotherapy, achieving high survival rates by means of complete surgical resection only. More... »

PAGES

23

Identifiers

URI

http://scigraph.springernature.com/pub.10.1186/s13569-015-0038-7

DOI

http://dx.doi.org/10.1186/s13569-015-0038-7

DIMENSIONS

https://app.dimensions.ai/details/publication/pub.1003993070

PUBMED

https://www.ncbi.nlm.nih.gov/pubmed/26524981


Indexing Status Check whether this publication has been indexed by Scopus and Web Of Science using the SN Indexing Status Tool
Incoming Citations Browse incoming citations for this publication using opencitations.net

JSON-LD is the canonical representation for SciGraph data.

TIP: You can open this SciGraph record using an external JSON-LD service: JSON-LD Playground Google SDTT

[
  {
    "@context": "https://springernature.github.io/scigraph/jsonld/sgcontext.json", 
    "about": [
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/11", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Medical and Health Sciences", 
        "type": "DefinedTerm"
      }, 
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/1112", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Oncology and Carcinogenesis", 
        "type": "DefinedTerm"
      }
    ], 
    "author": [
      {
        "affiliation": {
          "alternateName": "Department of Pathology, Rizzoli Institute, Via di Barbiano 1/10, 40136, Bologna, Italy", 
          "id": "http://www.grid.ac/institutes/grid.419038.7", 
          "name": [
            "Department of Pathology, Rizzoli Institute, Via di Barbiano 1/10, 40136, Bologna, Italy"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Righi", 
        "givenName": "Alberto", 
        "id": "sg:person.01115347567.94", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01115347567.94"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Department of Oncology, Rizzoli Institute, Bologna, Italy", 
          "id": "http://www.grid.ac/institutes/grid.419038.7", 
          "name": [
            "Department of Oncology, Rizzoli Institute, Bologna, Italy"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Paioli", 
        "givenName": "Anna", 
        "id": "sg:person.01235471460.73", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01235471460.73"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Department of Pathology, Treviso Regional Hospital, Treviso, Italy", 
          "id": "http://www.grid.ac/institutes/grid.413196.8", 
          "name": [
            "Department of Pathology, Rizzoli Institute, Via di Barbiano 1/10, 40136, Bologna, Italy", 
            "Department of Pathology, Treviso Regional Hospital, Treviso, Italy"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Dei Tos", 
        "givenName": "Angelo Paolo", 
        "id": "sg:person.01071327114.01", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01071327114.01"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Department of Pathology, Rizzoli Institute, Via di Barbiano 1/10, 40136, Bologna, Italy", 
          "id": "http://www.grid.ac/institutes/grid.419038.7", 
          "name": [
            "Department of Pathology, Rizzoli Institute, Via di Barbiano 1/10, 40136, Bologna, Italy"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Gambarotti", 
        "givenName": "Marco", 
        "id": "sg:person.01334463454.00", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01334463454.00"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Department of Oncology, Rizzoli Institute, Bologna, Italy", 
          "id": "http://www.grid.ac/institutes/grid.419038.7", 
          "name": [
            "Department of Oncology, Rizzoli Institute, Bologna, Italy"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Palmerini", 
        "givenName": "Emanuela", 
        "id": "sg:person.01210215667.35", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01210215667.35"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Department of Oncology, Rizzoli Institute, Bologna, Italy", 
          "id": "http://www.grid.ac/institutes/grid.419038.7", 
          "name": [
            "Department of Oncology, Rizzoli Institute, Bologna, Italy"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Cesari", 
        "givenName": "Manuela", 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Department of Oncology, Rizzoli Institute, Bologna, Italy", 
          "id": "http://www.grid.ac/institutes/grid.419038.7", 
          "name": [
            "Department of Oncology, Rizzoli Institute, Bologna, Italy"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Marchesi", 
        "givenName": "Emanuela", 
        "id": "sg:person.0720354404.13", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0720354404.13"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Department of Orthopaedic Oncology, Rizzoli Institute, Bologna, Italy", 
          "id": "http://www.grid.ac/institutes/grid.419038.7", 
          "name": [
            "Department of Orthopaedic Oncology, Rizzoli Institute, Bologna, Italy"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Donati", 
        "givenName": "Davide Maria", 
        "id": "sg:person.01202643430.41", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01202643430.41"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Department of Pathology, Rizzoli Institute, Via di Barbiano 1/10, 40136, Bologna, Italy", 
          "id": "http://www.grid.ac/institutes/grid.419038.7", 
          "name": [
            "Department of Pathology, Rizzoli Institute, Via di Barbiano 1/10, 40136, Bologna, Italy"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Picci", 
        "givenName": "Piero", 
        "id": "sg:person.0753274552.44", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0753274552.44"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Department of Oncology, Rizzoli Institute, Bologna, Italy", 
          "id": "http://www.grid.ac/institutes/grid.419038.7", 
          "name": [
            "Department of Oncology, Rizzoli Institute, Bologna, Italy"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Ferrari", 
        "givenName": "Stefano", 
        "id": "sg:person.013005321532.44", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.013005321532.44"
        ], 
        "type": "Person"
      }
    ], 
    "citation": [
      {
        "id": "sg:pub.10.1007/bf01267668", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1023996163", 
          "https://doi.org/10.1007/bf01267668"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1007/s00256-002-0534-8", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1015882473", 
          "https://doi.org/10.1007/s00256-002-0534-8"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1007/s00256-006-0123-3", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1012630351", 
          "https://doi.org/10.1007/s00256-006-0123-3"
        ], 
        "type": "CreativeWork"
      }
    ], 
    "datePublished": "2015-10-29", 
    "datePublishedReg": "2015-10-29", 
    "description": "BackgroundHigh-grade foci (grade 3 according to Broder\u2019s grading system) are sometimes detected in low-grade (grade 1 and 2) central osteosarcoma. The aim of this study was to retrospectively evaluate the clinical outcome in patients upgraded to high grade (grade 3) after a first diagnosis of low-grade osteosarcoma, following the detection of high-grade areas (grade 3) in the resected specimen.MethodsOf the 132 patients with a diagnosis of low-grade central osteosarcoma at surgical biopsy at our Institute, 33 patients were considered eligible for the study.ResultsMedian age was 37 (range 13\u201358\u00a0years). Location was in an extremity in 29 patients (88\u00a0%). Post-operative chemotherapy was given in 22 (67\u00a0%) patients. Follow-up data were available for all patients, with a median observation time of 115\u00a0months (range 4\u2013322\u00a0months). After histological revision, areas of high-grade (grade 3) osteosarcoma accounting for less than 50\u00a0% of the tumor were found in 20 (61\u00a0%) patients, whereas the majority of the tumor was composed of a high-grade (grade 3) component in 13 (39\u00a0%) patients. In the 20 cases of low-grade osteosarcoma with high-grade foci (grade 3) in less than 50\u00a0% of the tumor, 9 patients did not receive adjuvant chemotherapy; only one of them died, of unrelated causes. In the adjuvant chemotherapy group (11 out of 20 patients), one patient developed multiple lung metastases and died of disease 39\u00a0months after the first diagnosis. In the other 13 cases of low-grade osteosarcoma with high-grade foci (grade 3) in more than 50\u00a0% of the tumor, 12 patients received adjuvant chemotherapy: 2 had recurrence, 4 developed multiple lung metastases and 3 died of disease. The only patient who did not receive chemotherapy is alive without disease 232\u00a0months after complete surgical remission.ConclusionOur data indicate that patients with a diagnosis of low-grade osteosarcoma where the high-grade (grade 3) component is lower than 50\u00a0% of the resected specimen, may not require chemotherapy, achieving high survival rates by means of complete surgical resection only.", 
    "genre": "article", 
    "id": "sg:pub.10.1186/s13569-015-0038-7", 
    "isAccessibleForFree": true, 
    "isPartOf": [
      {
        "id": "sg:journal.1046367", 
        "issn": [
          "2045-3329"
        ], 
        "name": "Clinical Sarcoma Research", 
        "publisher": "Springer Nature", 
        "type": "Periodical"
      }, 
      {
        "issueNumber": "1", 
        "type": "PublicationIssue"
      }, 
      {
        "type": "PublicationVolume", 
        "volumeNumber": "5"
      }
    ], 
    "keywords": [
      "low-grade osteosarcoma", 
      "low-grade central osteosarcoma", 
      "multiple lung metastases", 
      "high-grade foci", 
      "high-grade component", 
      "central osteosarcoma", 
      "adjuvant chemotherapy", 
      "lung metastases", 
      "first diagnosis", 
      "complete surgical remission", 
      "median observation time", 
      "adjuvant chemotherapy group", 
      "post-operative chemotherapy", 
      "complete surgical resection", 
      "ResultsMedian age", 
      "chemotherapy group", 
      "surgical remission", 
      "unrelated causes", 
      "only patients", 
      "surgical resection", 
      "clinical outcomes", 
      "histological revision", 
      "surgical biopsy", 
      "ConclusionOur data", 
      "patients", 
      "chemotherapy", 
      "survival rate", 
      "osteosarcoma", 
      "tumors", 
      "higher survival rate", 
      "diagnosis", 
      "high grade", 
      "focal areas", 
      "months", 
      "metastasis", 
      "high-grade areas", 
      "observation time", 
      "remission", 
      "resection", 
      "biopsy", 
      "recurrence", 
      "MethodsOf", 
      "extremities", 
      "disease", 
      "age", 
      "outcomes", 
      "cases", 
      "cause", 
      "study", 
      "grade", 
      "group", 
      "aim", 
      "majority", 
      "specimen", 
      "data", 
      "area", 
      "Institute", 
      "focus", 
      "revision", 
      "rate", 
      "detection", 
      "components", 
      "time", 
      "location", 
      "means"
    ], 
    "name": "High-grade focal areas in low-grade central osteosarcoma: high-grade or still low-grade osteosarcoma?", 
    "pagination": "23", 
    "productId": [
      {
        "name": "dimensions_id", 
        "type": "PropertyValue", 
        "value": [
          "pub.1003993070"
        ]
      }, 
      {
        "name": "doi", 
        "type": "PropertyValue", 
        "value": [
          "10.1186/s13569-015-0038-7"
        ]
      }, 
      {
        "name": "pubmed_id", 
        "type": "PropertyValue", 
        "value": [
          "26524981"
        ]
      }
    ], 
    "sameAs": [
      "https://doi.org/10.1186/s13569-015-0038-7", 
      "https://app.dimensions.ai/details/publication/pub.1003993070"
    ], 
    "sdDataset": "articles", 
    "sdDatePublished": "2022-10-01T06:41", 
    "sdLicense": "https://scigraph.springernature.com/explorer/license/", 
    "sdPublisher": {
      "name": "Springer Nature - SN SciGraph project", 
      "type": "Organization"
    }, 
    "sdSource": "s3://com-springernature-scigraph/baseset/20221001/entities/gbq_results/article/article_674.jsonl", 
    "type": "ScholarlyArticle", 
    "url": "https://doi.org/10.1186/s13569-015-0038-7"
  }
]
 

Download the RDF metadata as:  json-ld nt turtle xml License info

HOW TO GET THIS DATA PROGRAMMATICALLY:

JSON-LD is a popular format for linked data which is fully compatible with JSON.

curl -H 'Accept: application/ld+json' 'https://scigraph.springernature.com/pub.10.1186/s13569-015-0038-7'

N-Triples is a line-based linked data format ideal for batch operations.

curl -H 'Accept: application/n-triples' 'https://scigraph.springernature.com/pub.10.1186/s13569-015-0038-7'

Turtle is a human-readable linked data format.

curl -H 'Accept: text/turtle' 'https://scigraph.springernature.com/pub.10.1186/s13569-015-0038-7'

RDF/XML is a standard XML format for linked data.

curl -H 'Accept: application/rdf+xml' 'https://scigraph.springernature.com/pub.10.1186/s13569-015-0038-7'


 

This table displays all metadata directly associated to this object as RDF triples.

207 TRIPLES      21 PREDICATES      93 URIs      82 LITERALS      7 BLANK NODES

Subject Predicate Object
1 sg:pub.10.1186/s13569-015-0038-7 schema:about anzsrc-for:11
2 anzsrc-for:1112
3 schema:author Nf2b52d8b08aa4f9f83441741e7e3faa4
4 schema:citation sg:pub.10.1007/bf01267668
5 sg:pub.10.1007/s00256-002-0534-8
6 sg:pub.10.1007/s00256-006-0123-3
7 schema:datePublished 2015-10-29
8 schema:datePublishedReg 2015-10-29
9 schema:description BackgroundHigh-grade foci (grade 3 according to Broder’s grading system) are sometimes detected in low-grade (grade 1 and 2) central osteosarcoma. The aim of this study was to retrospectively evaluate the clinical outcome in patients upgraded to high grade (grade 3) after a first diagnosis of low-grade osteosarcoma, following the detection of high-grade areas (grade 3) in the resected specimen.MethodsOf the 132 patients with a diagnosis of low-grade central osteosarcoma at surgical biopsy at our Institute, 33 patients were considered eligible for the study.ResultsMedian age was 37 (range 13–58 years). Location was in an extremity in 29 patients (88 %). Post-operative chemotherapy was given in 22 (67 %) patients. Follow-up data were available for all patients, with a median observation time of 115 months (range 4–322 months). After histological revision, areas of high-grade (grade 3) osteosarcoma accounting for less than 50 % of the tumor were found in 20 (61 %) patients, whereas the majority of the tumor was composed of a high-grade (grade 3) component in 13 (39 %) patients. In the 20 cases of low-grade osteosarcoma with high-grade foci (grade 3) in less than 50 % of the tumor, 9 patients did not receive adjuvant chemotherapy; only one of them died, of unrelated causes. In the adjuvant chemotherapy group (11 out of 20 patients), one patient developed multiple lung metastases and died of disease 39 months after the first diagnosis. In the other 13 cases of low-grade osteosarcoma with high-grade foci (grade 3) in more than 50 % of the tumor, 12 patients received adjuvant chemotherapy: 2 had recurrence, 4 developed multiple lung metastases and 3 died of disease. The only patient who did not receive chemotherapy is alive without disease 232 months after complete surgical remission.ConclusionOur data indicate that patients with a diagnosis of low-grade osteosarcoma where the high-grade (grade 3) component is lower than 50 % of the resected specimen, may not require chemotherapy, achieving high survival rates by means of complete surgical resection only.
10 schema:genre article
11 schema:isAccessibleForFree true
12 schema:isPartOf N177b92418e8b4becab9bd1e92b4cffc2
13 Naf1dff6d85b64f89951d75afe5419173
14 sg:journal.1046367
15 schema:keywords ConclusionOur data
16 Institute
17 MethodsOf
18 ResultsMedian age
19 adjuvant chemotherapy
20 adjuvant chemotherapy group
21 age
22 aim
23 area
24 biopsy
25 cases
26 cause
27 central osteosarcoma
28 chemotherapy
29 chemotherapy group
30 clinical outcomes
31 complete surgical remission
32 complete surgical resection
33 components
34 data
35 detection
36 diagnosis
37 disease
38 extremities
39 first diagnosis
40 focal areas
41 focus
42 grade
43 group
44 high grade
45 high-grade areas
46 high-grade component
47 high-grade foci
48 higher survival rate
49 histological revision
50 location
51 low-grade central osteosarcoma
52 low-grade osteosarcoma
53 lung metastases
54 majority
55 means
56 median observation time
57 metastasis
58 months
59 multiple lung metastases
60 observation time
61 only patients
62 osteosarcoma
63 outcomes
64 patients
65 post-operative chemotherapy
66 rate
67 recurrence
68 remission
69 resection
70 revision
71 specimen
72 study
73 surgical biopsy
74 surgical remission
75 surgical resection
76 survival rate
77 time
78 tumors
79 unrelated causes
80 schema:name High-grade focal areas in low-grade central osteosarcoma: high-grade or still low-grade osteosarcoma?
81 schema:pagination 23
82 schema:productId N03b927d7362c4a1f895645bfb38cece3
83 N7fb418f3649a4a68a5fc762bf1d85652
84 N90b5652f42504d479c5e054f2bd2c634
85 schema:sameAs https://app.dimensions.ai/details/publication/pub.1003993070
86 https://doi.org/10.1186/s13569-015-0038-7
87 schema:sdDatePublished 2022-10-01T06:41
88 schema:sdLicense https://scigraph.springernature.com/explorer/license/
89 schema:sdPublisher Nfc2f5900af5544d3b3f8358260b5eff7
90 schema:url https://doi.org/10.1186/s13569-015-0038-7
91 sgo:license sg:explorer/license/
92 sgo:sdDataset articles
93 rdf:type schema:ScholarlyArticle
94 N03b927d7362c4a1f895645bfb38cece3 schema:name pubmed_id
95 schema:value 26524981
96 rdf:type schema:PropertyValue
97 N177b92418e8b4becab9bd1e92b4cffc2 schema:issueNumber 1
98 rdf:type schema:PublicationIssue
99 N193dfe0e79bf49afa3124e663b75f866 rdf:first sg:person.01071327114.01
100 rdf:rest N1aff57684c08409eaccb648d334afaa1
101 N1aff57684c08409eaccb648d334afaa1 rdf:first sg:person.01334463454.00
102 rdf:rest N7bafa4dc0cb249fe8b7c0719a290a8d6
103 N1b55f3b1130243ffb47e804e33533ee7 rdf:first sg:person.0720354404.13
104 rdf:rest Nd3388298861c4206bd2c439e82df6a71
105 N7343d2c360fa4e56b9f98de0627f9fec rdf:first sg:person.01235471460.73
106 rdf:rest N193dfe0e79bf49afa3124e663b75f866
107 N7bafa4dc0cb249fe8b7c0719a290a8d6 rdf:first sg:person.01210215667.35
108 rdf:rest Ncf7c81f5c2ca490b91c5535e087940fb
109 N7fb418f3649a4a68a5fc762bf1d85652 schema:name dimensions_id
110 schema:value pub.1003993070
111 rdf:type schema:PropertyValue
112 N90b5652f42504d479c5e054f2bd2c634 schema:name doi
113 schema:value 10.1186/s13569-015-0038-7
114 rdf:type schema:PropertyValue
115 N969d3611c0b540b0a5970614805cb559 schema:affiliation grid-institutes:grid.419038.7
116 schema:familyName Cesari
117 schema:givenName Manuela
118 rdf:type schema:Person
119 Naf1dff6d85b64f89951d75afe5419173 schema:volumeNumber 5
120 rdf:type schema:PublicationVolume
121 Ncf7c81f5c2ca490b91c5535e087940fb rdf:first N969d3611c0b540b0a5970614805cb559
122 rdf:rest N1b55f3b1130243ffb47e804e33533ee7
123 Nd3388298861c4206bd2c439e82df6a71 rdf:first sg:person.01202643430.41
124 rdf:rest Nf5f7d207b07c45f1863ba7d4ede21611
125 Nd4dcfd8acf5a4176a0872fb30f6b897a rdf:first sg:person.013005321532.44
126 rdf:rest rdf:nil
127 Nf2b52d8b08aa4f9f83441741e7e3faa4 rdf:first sg:person.01115347567.94
128 rdf:rest N7343d2c360fa4e56b9f98de0627f9fec
129 Nf5f7d207b07c45f1863ba7d4ede21611 rdf:first sg:person.0753274552.44
130 rdf:rest Nd4dcfd8acf5a4176a0872fb30f6b897a
131 Nfc2f5900af5544d3b3f8358260b5eff7 schema:name Springer Nature - SN SciGraph project
132 rdf:type schema:Organization
133 anzsrc-for:11 schema:inDefinedTermSet anzsrc-for:
134 schema:name Medical and Health Sciences
135 rdf:type schema:DefinedTerm
136 anzsrc-for:1112 schema:inDefinedTermSet anzsrc-for:
137 schema:name Oncology and Carcinogenesis
138 rdf:type schema:DefinedTerm
139 sg:journal.1046367 schema:issn 2045-3329
140 schema:name Clinical Sarcoma Research
141 schema:publisher Springer Nature
142 rdf:type schema:Periodical
143 sg:person.01071327114.01 schema:affiliation grid-institutes:grid.413196.8
144 schema:familyName Dei Tos
145 schema:givenName Angelo Paolo
146 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01071327114.01
147 rdf:type schema:Person
148 sg:person.01115347567.94 schema:affiliation grid-institutes:grid.419038.7
149 schema:familyName Righi
150 schema:givenName Alberto
151 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01115347567.94
152 rdf:type schema:Person
153 sg:person.01202643430.41 schema:affiliation grid-institutes:grid.419038.7
154 schema:familyName Donati
155 schema:givenName Davide Maria
156 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01202643430.41
157 rdf:type schema:Person
158 sg:person.01210215667.35 schema:affiliation grid-institutes:grid.419038.7
159 schema:familyName Palmerini
160 schema:givenName Emanuela
161 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01210215667.35
162 rdf:type schema:Person
163 sg:person.01235471460.73 schema:affiliation grid-institutes:grid.419038.7
164 schema:familyName Paioli
165 schema:givenName Anna
166 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01235471460.73
167 rdf:type schema:Person
168 sg:person.013005321532.44 schema:affiliation grid-institutes:grid.419038.7
169 schema:familyName Ferrari
170 schema:givenName Stefano
171 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.013005321532.44
172 rdf:type schema:Person
173 sg:person.01334463454.00 schema:affiliation grid-institutes:grid.419038.7
174 schema:familyName Gambarotti
175 schema:givenName Marco
176 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01334463454.00
177 rdf:type schema:Person
178 sg:person.0720354404.13 schema:affiliation grid-institutes:grid.419038.7
179 schema:familyName Marchesi
180 schema:givenName Emanuela
181 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0720354404.13
182 rdf:type schema:Person
183 sg:person.0753274552.44 schema:affiliation grid-institutes:grid.419038.7
184 schema:familyName Picci
185 schema:givenName Piero
186 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0753274552.44
187 rdf:type schema:Person
188 sg:pub.10.1007/bf01267668 schema:sameAs https://app.dimensions.ai/details/publication/pub.1023996163
189 https://doi.org/10.1007/bf01267668
190 rdf:type schema:CreativeWork
191 sg:pub.10.1007/s00256-002-0534-8 schema:sameAs https://app.dimensions.ai/details/publication/pub.1015882473
192 https://doi.org/10.1007/s00256-002-0534-8
193 rdf:type schema:CreativeWork
194 sg:pub.10.1007/s00256-006-0123-3 schema:sameAs https://app.dimensions.ai/details/publication/pub.1012630351
195 https://doi.org/10.1007/s00256-006-0123-3
196 rdf:type schema:CreativeWork
197 grid-institutes:grid.413196.8 schema:alternateName Department of Pathology, Treviso Regional Hospital, Treviso, Italy
198 schema:name Department of Pathology, Rizzoli Institute, Via di Barbiano 1/10, 40136, Bologna, Italy
199 Department of Pathology, Treviso Regional Hospital, Treviso, Italy
200 rdf:type schema:Organization
201 grid-institutes:grid.419038.7 schema:alternateName Department of Oncology, Rizzoli Institute, Bologna, Italy
202 Department of Orthopaedic Oncology, Rizzoli Institute, Bologna, Italy
203 Department of Pathology, Rizzoli Institute, Via di Barbiano 1/10, 40136, Bologna, Italy
204 schema:name Department of Oncology, Rizzoli Institute, Bologna, Italy
205 Department of Orthopaedic Oncology, Rizzoli Institute, Bologna, Italy
206 Department of Pathology, Rizzoli Institute, Via di Barbiano 1/10, 40136, Bologna, Italy
207 rdf:type schema:Organization
 




Preview window. Press ESC to close (or click here)


...